Pharmaceutical

Boehringer Ingelheim and Salipro enter drug discovery partnership

Boehringer Ingelheim and Sweden-based Salipro Biotech have entered a research and licence agreement for drug targets' development.

Mar 15, 2025 - 06:00
Boehringer Ingelheim and Salipro enter drug discovery partnership
Boehringer Ingelheim and Sweden-based Salipro Biotech have entered a research and licence agreement for drug targets' development.
Read the original article

Tags:

Previous Article

AstraZeneca director says AI must be a “thought partner” in drug discovery

Next Article

MeiraGTx and Hologen launch AI-backed gene therapy venture

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

For Eli Lilly’s head scientist, Alzheimer’s results cap a 25-year scientific quest

For Eli Lilly’s head scientist, Alzheimer’s results cap...

May 3, 2023

STAT+: FDA clears first over-the-counter continuous glucose monitor

STAT+: FDA clears first over-the-counter continuous glu...

Mar 6, 2024

STAT+: Amgen reports first clinical data on new targeted cancer therapy

STAT+: Amgen reports first clinical data on new targete...

Oct 14, 2023